Autopsy report · NCT00328081

State of Obesity Care in Canada Evaluation Registry

“Principal Investigator left the institution”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 3 months before it stopped.
• 1,906 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Hamilton Health Sciences Corporation

Sponsor type

University, hospital or other

Conditions

Obesity; Morbid Obesity

Participants

1,906

Sites

1

Countries

Canada

Trials that died the same way

• Detailed Clinical, Biochemical and Genetic Characterization in Gonadotropin-releasing Hormone (GnRH) Deficiency Disorders
  “the Principal Investigator left the institution” (98% match in meaning)
• Identification and Characterization of Molecular Markers in Musculoskeletal Tumors
  “Principal Investigator has left the Institution” (98% match in meaning)
• Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM)
  “Original Principal Investigator left the institution.” (96% match in meaning)
• Prepectoral vs Partial Subpectoral Two-Stage Implant-Based Breast Reconstruction
  “Principal Investigator left institution” (95% match in meaning)
• Melphalan on Disease Burden Measured by Next Generation Sequencing Before AHCT (Autologous Hematopoietic Cell Transplant) for Multiple Myeloma
  “The original principal Investigator left the institution.” (95% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.